These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9530682)

  • 1. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
    Cook PR
    Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T; Klimek L
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.
    Calderon MA; Eichel A; Makatsori M; Pfaar O
    Curr Opin Allergy Clin Immunol; 2012 Jun; 12(3):249-56. PubMed ID: 22499145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allergen specific immunotherapy: new approaches].
    Tay F; Kündig TM; Senti G
    Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
    Wise SK; Schlosser RJ
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analyses of specific immunotherapy trials.
    Calderon MA
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for hayfever.
    Durham SR; Walker S
    Chem Immunol; 2000; 78():199-208. PubMed ID: 12847731
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of sublingual immunotherapy (SLIT).
    Radulovic S; Wilson D; Calderon M; Durham S
    Allergy; 2011 Jun; 66(6):740-52. PubMed ID: 21443635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do indications to sublingual immunotherapy need to be revised?
    Incorvaia C; Mauro M
    J Allergy Clin Immunol; 2010 Jan; 125(1):277; author reply 277-8. PubMed ID: 20109757
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?
    Wise SK; Schlosser RJ
    Am J Rhinol Allergy; 2012; 26(1):18-22. PubMed ID: 22391071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.